These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 15382956)

  • 1. Vaginal rings for menopausal symptom relief.
    Ballagh SA
    Drugs Aging; 2004; 21(12):757-66. PubMed ID: 15382956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative study of the effects of an estradiol-releasing vaginal ring combined with an oral gestagen versus transdermal estrogen combined with a levonorgestrel-releasing IUD: clinical findings and endometrial response.
    Kalogirou D; Antoniou G; Karakitsos P; Kalogirou O; Antoniou D; Giannikos L
    Int J Fertil Menopausal Stud; 1996; 41(6):522-7. PubMed ID: 9010746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaginal hormone therapy for urogenital and menopausal symptoms.
    Ballagh SA
    Semin Reprod Med; 2005 May; 23(2):126-40. PubMed ID: 15852198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estradiol/progesterone-releasing vaginal rings for hormone replacement therapy in postmenopausal women.
    Hamada AL; Maruo T; Samoto T; Yoshida S; Nash H; Spitz IM; Johansson E
    Gynecol Endocrinol; 2003 Jun; 17(3):247-54. PubMed ID: 12857433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogens and the urogenital tract. Studies on steroid hormone receptors and a clinical study on a new estradiol-releasing vaginal ring.
    Smith P
    Acta Obstet Gynecol Scand Suppl; 1993; 157():1-26. PubMed ID: 8393609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaginal ring delivering estradiol and progesterone: a possible alternative to relieve climacteric symptoms.
    Ben-Chetrit A; Hochner-Celnikier D; Lindenberg T; Zacut D; Shimonovitz S; Gelber H; Spitz IM
    Isr Med Assoc J; 2005 May; 7(5):302-6. PubMed ID: 15909462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endometrial and vaginal effects of low-dose estradiol delivered by vaginal ring or vaginal tablet.
    Weisberg E; Ayton R; Darling G; Farrell E; Murkies A; O'Neill S; Kirkegard Y; Fraser IS
    Climacteric; 2005 Mar; 8(1):83-92. PubMed ID: 15804736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 17beta-estradiol vaginal tablet versus conjugated equine estrogen vaginal cream to relieve menopausal atrophic vaginitis.
    Rioux JE; Devlin C; Gelfand MM; Steinberg WM; Hepburn DS
    Menopause; 2000; 7(3):156-61. PubMed ID: 10810960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaginal ring delivery of hormone replacement therapy--a review.
    Dezarnaulds G; Fraser IS
    Expert Opin Pharmacother; 2003 Feb; 4(2):201-12. PubMed ID: 12562310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Contraception in the hypertensive woman using a vaginal ring delivering estradiol and norgestrel].
    Elkik F; Basdevant A; Corvol P
    Arch Mal Coeur Vaiss; 1985 Oct; 78(11):1737-9. PubMed ID: 3938250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contraception for the perimenopausal patient.
    Upton GV
    Obstet Gynecol Clin North Am; 1987 Mar; 14(1):207-27. PubMed ID: 3306520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New delivery systems in contraception: vaginal rings.
    Johansson ED; Sitruk-Ware R
    Am J Obstet Gynecol; 2004 Apr; 190(4 Suppl):S54-9. PubMed ID: 15105799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endometrial effect of progesterone delivered by vaginal rings in estrogen-treated postmenopausal women.
    Noé G; Sitruk-Ware R; Zegers-Hochschild F; Variano B; Montero JC; Arriagada P; Li A; Stanczyk FZ; Felix JC; Mishell DR; Croxatto HB
    Climacteric; 2010 Oct; 13(5):433-41. PubMed ID: 20642326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of compounded bioidentical transdermal hormone therapy on hemostatic, inflammatory, immune factors; cardiovascular biomarkers; quality-of-life measures; and health outcomes in perimenopausal and postmenopausal women.
    Stephenson K; Neuenschwander PF; Kurdowska AK
    Int J Pharm Compd; 2013; 17(1):74-85. PubMed ID: 23627249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transdermal delivery of sex steroids for hormone replacement therapy and contraception. A review of principles and practice.
    Henzl MR; Loomba PK
    J Reprod Med; 2003 Jul; 48(7):525-40. PubMed ID: 12953327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endometrial morphology during hormone replacement therapy with estradiol gel combined to levonorgestrel-releasing intrauterine device or natural progesterone.
    Suvanto-Luukkonen E; Malinen H; Sundström H; Penttinen J; Kauppila A
    Acta Obstet Gynecol Scand; 1998 Aug; 77(7):758-63. PubMed ID: 9740525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaginal ring contraception.
    Kerns J; Darney P
    Contraception; 2011 Feb; 83(2):107-15. PubMed ID: 21237335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel regimen of combination transdermal estrogen and intermittent vaginally administered progesterone for relief of menopausal symptoms.
    Kroft J; Klostermann NR; Moody JR; Taerk E; Wolfman W
    Gynecol Endocrinol; 2010 Dec; 26(12):902-8. PubMed ID: 20486879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endometrial response to a cyclic regimen of percutaneous 17beta-estradiol and low-dose vaginal micronized progesterone in women with mild-to-moderate hypertension.
    Vilodre LC; Osório Wender MC; Sisson de Castro JA; dos Reis FM; Ruschel S; Magalhães JA; Spritzer PM
    Gynecol Endocrinol; 2003 Aug; 17(4):323-8. PubMed ID: 14503977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contraceptive vaginal rings.
    Harwood B; Mishell DR
    Semin Reprod Med; 2001 Dec; 19(4):381-90. PubMed ID: 11727180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.